Leerink Partnrs Expects Higher Earnings for Tenet Healthcare

Tenet Healthcare Corporation (NYSE:THC) – Equities research analysts at Leerink Partnrs increased their Q3 2025 EPS estimates for shares of Tenet Healthcare in a research report issued to clients and investors on Wednesday, July 23rd. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $3.13 per share for the quarter, up from their previous estimate of $2.28. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $4.10 EPS, FY2025 earnings at $15.61 EPS, Q1 2026 earnings at $4.34 EPS, Q2 2026 earnings at $3.95 EPS, Q4 2026 earnings at $4.10 EPS, FY2026 earnings at $15.56 EPS, FY2027 earnings at $18.78 EPS, FY2028 earnings at $21.72 EPS and FY2029 earnings at $24.32 EPS.

Other equities analysts have also issued research reports about the stock. The Goldman Sachs Group lifted their price target on shares of Tenet Healthcare from $134.00 to $154.00 and gave the company a “neutral” rating in a report on Monday, May 5th. Raymond James Financial restated an “outperform” rating and set a $200.00 price target (up from $185.00) on shares of Tenet Healthcare in a research note on Wednesday, July 23rd. Bank of America raised their price target on shares of Tenet Healthcare from $165.00 to $180.00 and gave the company a “buy” rating in a report on Wednesday, May 14th. Guggenheim upped their price target on shares of Tenet Healthcare from $180.00 to $188.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, Truist Financial lifted their price objective on shares of Tenet Healthcare from $190.00 to $205.00 and gave the company a “buy” rating in a research note on Wednesday, July 16th. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $190.00.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $156.47 on Monday. Tenet Healthcare has a 1 year low of $109.82 and a 1 year high of $185.25. The company has a debt-to-equity ratio of 2.39, a quick ratio of 1.63 and a current ratio of 1.71. The firm has a 50 day moving average price of $167.72 and a 200 day moving average price of $145.67. The company has a market cap of $14.53 billion, a price-to-earnings ratio of 10.02, a PEG ratio of 0.67 and a beta of 1.64.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.84 by $1.18. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%. The firm had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. During the same period last year, the company earned $2.31 EPS. The firm’s quarterly revenue was up 3.2% on a year-over-year basis.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors have recently modified their holdings of the company. US Bancorp DE increased its stake in shares of Tenet Healthcare by 0.8% in the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock valued at $1,159,000 after purchasing an additional 68 shares during the period. Farther Finance Advisors LLC raised its stake in Tenet Healthcare by 2.8% during the 2nd quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company’s stock valued at $460,000 after acquiring an additional 70 shares in the last quarter. Lindbrook Capital LLC grew its stake in shares of Tenet Healthcare by 5.3% in the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock worth $192,000 after purchasing an additional 72 shares in the last quarter. Signaturefd LLC raised its stake in shares of Tenet Healthcare by 11.2% during the second quarter. Signaturefd LLC now owns 732 shares of the company’s stock valued at $129,000 after purchasing an additional 74 shares in the last quarter. Finally, Vista Investment Partners LLC lifted its holdings in Tenet Healthcare by 0.3% in the second quarter. Vista Investment Partners LLC now owns 25,257 shares of the company’s stock worth $4,445,000 after purchasing an additional 76 shares during the period. Institutional investors own 95.44% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Paola M. Arbour sold 7,738 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the transaction, the executive vice president directly owned 20,110 shares in the company, valued at $3,479,030. This trade represents a 27.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Thomas W. Arnst sold 9,786 shares of the stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of $166.00, for a total transaction of $1,624,476.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 54,121 shares of company stock worth $8,846,305. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.